Response to Influenza Vaccination in Lymphoma Patients Treated With Rituximab

Clinical trial NCT01707628 · COMPLETED

Trial details

NCT number: NCT01707628
Sponsor: St. Antonius Hospital
Status: COMPLETED
Phase: Not Applicable
Study type: INTERVENTIONAL

Non-Hodgkin Lymphoma (NHL)

Start date: 2012-10-01
Primary completion: 2013-06-01
Enrollment: 98

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.